San Diego, California-based Aardvark Therapeutics, Inc. will make its trading debut on the Nasdaq Global Market, under the ticker symbol, "AARD" today, Feb. 13 , 2025.
This clinical-stage biopharmaceutical company, founded in 2017, is developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
About 5.888 million shares will be sold in the public offering at a price of $16 per share.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.